MLICM
CRDF icon

Metropolitan Life Insurance Company (MetLife)’s Cardiff Oncology CRDF Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-11,065
Closed -$73.7K – 2791
2021
Q3 		$73.7K Buy
+11,065
New +$69.5K ﹤0.01% 2681
2015
Q3 		– Sell
-264
Closed -$193K – 2683
2015
Q2 		$193K Buy
+264
New +$187K ﹤0.01% 2427

Other funds holding CRDF

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s CRDF Position: Q4 2021 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Cardiff Oncology (CRDF) in Q4 2021, closing a stake of 11,065 shares — an estimated $73.7K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in CRDF in Q2 2015 and held it in 2 quarters. The position peaked at $193K in Q2 2015. 87 funds tracked by Wall St. Rank hold CRDF as of Q4 2021.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Cardiff Oncology position as of Q4 2021 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 11,065 Cardiff Oncology shares in Q4 2021, an estimated $73.7K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Cardiff Oncology in Q2 2015 and held it in 2 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Cardiff Oncology position peaked at $193K in Q2 2015.
  • 87 funds tracked by Wall St. Rank held Cardiff Oncology as of Q4 2021.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q4 2021, filed 15 Feb 2022.